Clinical Trial Update: Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose [Phase 4]

View source ↗

Summary

This Phase 4 study reports immune responses in adults after revaccination with ADACEL (diphtheria, tetanus, and acellular pertussis) vaccine given 10 years afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pertussis, Tetanus | Phase 4 | Status: COMPLETED | Results posted: 2014-04-30